Literature DB >> 1586982

Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.

A Begleiter1, L Verburg, L G Israels, J B Johnston.   

Abstract

Permeabilized L5178Y cells were used to investigate the mechanism underlying inhibition of the repair of irradiation-induced DNA strand breaks by 2'-deoxycoformycin combined with deoxyadenosine. Permeabilized cells repaired DNA strand breaks as effectively as did intact cells, and at deoxyadenosine concentrations that produced similar levels of deoxyadenosine triphosphate (dATP), repair of DNA strand breaks was inhibited by 2'-deoxycoformycin plus deoxyadenosine to a comparable extent in both types of cells. Accompanying the increase in intracellular dATP produced by 2'-deoxycoformycin combined with deoxyadenosine was a fall in levels of deoxythymidine triphosphate (dTTP), deoxyguanosine triphosphate (dGTP), and deoxycytidine triphosphate (dCTP). The addition of dTTP, dGTP, and dCTP reversed the inhibition of DNA repair by 2'-deoxycoformycin plus deoxyadenosine, although the level of dATP was not affected. Reducing the phosphorylation of deoxy-adenosine to dATP by the addition of adenosine prevented the decrease in levels of dTTP, dGTP, and dCTP and the inhibition of DNA repair by 2'-deoxycoformycin and deoxyadenosine. In contrast, increasing the intracellular levels of dATP by the addition of 2'-deoxycoformycin together with dATP, deoxyadenosine diphosphate (dADP), or deoxyadenosine monophosphate (dAMP) had no effect on the levels of the other deoxynucleotide triphosphates and did not inhibit DNA repair. Moreover, DNA repair was not inhibited by the breakdown products of deoxyadenosine, adenine, or deoxyribose. These results suggest that inhibition of the repair of irradiation-induced DNA strand breaks by 2'-deoxycoformycin combined with deoxyadenosine requires the phosphorylation of deoxyadenosine and involves alterations in the levels of deoxynucleotide triphosphates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586982     DOI: 10.1007/bf00686487

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  23 in total

1.  D-ribose inhibits DNA repair synthesis in human lymphocytes.

Authors:  G Zunica; M Marini; M A Brunelli; M Chiricolo; C Franceschi
Journal:  Biochem Biophys Res Commun       Date:  1986-07-31       Impact factor: 3.575

2.  Compartmentation of guanine nucleotide precursors for DNA synthesis.

Authors:  B T Nguyen; W Sadée
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

3.  Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.

Authors:  A Begleiter; L Pugh; L G Israels; J B Johnston
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

4.  Characterization of deoxyribonucleic acid repair synthesis in permeable human fibroblasts.

Authors:  S L Dresler; J D Roberts; M W Lieberman
Journal:  Biochemistry       Date:  1982-05-11       Impact factor: 3.162

5.  Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.

Authors:  A S Bagnara; M S Hershfield
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation.

Authors:  D Hunting; J F Henderson
Journal:  Can J Biochem       Date:  1981-09

7.  The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.

Authors:  S S Matsumoto; J Yu; A L Yu
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

8.  Low-dose deoxycoformycin in lymphoid malignancy.

Authors:  M R Grever; J M Leiby; E H Kraut; H E Wilson; J A Neidhart; R L Wall; S P Balcerzak
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

9.  Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.

Authors:  S Seto; C J Carrera; D B Wasson; D A Carson
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

10.  Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).

Authors:  A S Spiers; D Moore; P A Cassileth; D P Harrington; F J Cummings; R S Neiman; J M Bennett; M J O'Connell
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

View more
  3 in total

1.  4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro.

Authors:  E I Kodama; S Kohgo; K Kitano; H Machida; H Gatanaga; S Shigeta; M Matsuoka; H Ohrui; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 2.  Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

3.  Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia.

Authors:  Sara E F Kost; Ali Saleh; Edgard M Mejia; Marina Mostafizar; Eric D J Bouchard; Versha Banerji; Aaron J Marshall; Spencer B Gibson; James B Johnston; Sachin Katyal
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.